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If you are directing or supervising a clinic or physician's office laboratory (POL) 
that will be regulated by the Federal government for the first time, this brochure 
will introduce you to the new regulatory requirements. Some of the most 
common questions are answered and you can learn how to obtain further 
information about how the regulations will apply to your unique laboratory 
situation.
Q. What is CLIA, and w hat w ill i t  do for me?
CK. In 1988, several media reports focused public and Congressional
attention on deficiencies in the quality of services provided by some of 
the Nation’s clinical laboratories. The Clinical Laboratory Improve­
ment Amendments of 1988, or CLIA, resulted from Congressional 
examination of the situation, including investigation of testing per­
formed in POLs. CLIA sets standards designed to improve quality in 
all laboratory testing and includes specifications for quality control, 
quality assurance, patient test management, personnel and proficiency 
testing.
In determining the final regulations to implement CLIA, the Depart­
ment of Health and Human Services considered thousands of public 
comments to the proposed regulations and consulted with many 
clinicians and others who have clinical laboratory testing expertise.
The regulations set minimum standards for laboratory practice and 
quality. When your laboratory satisfies CLIA regulatory requirements, 
you as well as your patients can have greater confidence in the quality 
and reliability of your laboratory results.
Q- S ince I perform  on ly  a few  sim ple tests in  my office, do 
CLIA regulations apply to  m y practice?
jjf. Yes. CLIA regulations concern all laboratory testing used for the
assessment of human health or the diagnosis, prevention, or treatment 
of disease. CLIA applies to every laboratory and testing site in the 
United States, even if only a few basic tests are performed as part of 
physical examinations.
Some simple tests are waived from specific CLIA requirements. If 
your laboratory performs only these tests, you need to obtain a certifi­
cate of waiver to show that your laboratory is exempt from specific 
CLIA requirements.
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Q. If I do only d ipstick  urinalyses and spun hem atocrits  
on my patients, is my laboratory elig ib le  for a waiver?
5Ï. Yes. These procedures are among the eight tests exempt from specific 
CLIA standards. The eight tests are as follows:
Dipstick or tablet urinalysis (nonautomated)
Fecal occult blood
Ovulation test using visual color comparison 
Urine pregnancy test using visual color comparison 
Erythrocyte sedimentation rate 
Hemoglobin by copper sulfate method
• Spun microhematocrit
Blood glucose using certain devices cleared by the Food and 
Drug Administration (FDA) specifically for home use
If you perform only the tests on this list and no others, you must obtain 
a certificate of waiver. While no specific CLIA regulations apply to the 
performance of these tests, you are expected to follow the test 
manufacturer’s instructions. Laboratories with certificates of waiver 
will not be inspected routinely; however, they may be inspected as part 
of complaint investigations and on a random basis to determine 
whether only the waived tests are being performed.
Q. What if  my laboratory perform s tests not on the lis t  of 
w aived procedures?
r%' All tests not listed as waived are divided into one of two categories,
moderate complexity or high complexity, based on the complexity of 
the testing procedure. For both of these categories the CLIA regula­
tions list specific requirements for proficiency testing, patient test 
management, quality control, quality assurance, personnel, and 
inspections. Most testing performed in POLs or which is essential for 
immediate patient care is categorized as moderate complexity, unless it 
is waived. More than 40 general methodologies which include several 
thousand specific test systems, assays or examinations are listed in this 
category. Some examples of moderate complexity tests are microscopic 
analysis of urinary sediment, throat cultures, Gram stains, and hematol­
ogy and chemistry tests conducted on fully automated instruments that 
do not require operator intervention during the analytic process.
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Q. How can I determ ine w hether a test my laboratory
perform s is classified  as m oderate or h igh com plexity?
j/f. A preliminary listing of several thousand test systems, assays, and
examinations in both the moderate and high complexity categories was 
published in the Federal Register on the same day the CLIA regulations 
were published. A complete list will be published within 6 months of 
this date in the Federal Register. Thereafter, updates will be published 
periodically. See page 8 of this brochure for instructions on obtaining a 
copy of the Federal Register.
Q ■ What are the major d ifferences betw een  the
requirem ents for laboratories perform ing tests o f  
m oderate and high com plexity?
!%. The major differences in requirements between moderate and high 
complexity testing concern quality control (QC) and personnel stan­
dards. Laboratories performing high complexity testing must com­
pletely meet the QC requirements by the effective date of the regula­
tions, whereas some QC standards for moderate complexity testing are 
being implemented in stages.
Personnel standards for high complexity testing are more rigorous than 
those for moderate complexity testing since the testing itself is more 
complicated. In general, personnel conducting high complexity testing 
will need more education and experience than those doing moderate 
complexity testing.
Q • If my laboratory conducts on ly  testin g  o f m oderate  
com plexity, m ust I h ire a pathologist as laboratory  
director?
jZ . No. The personnel regulations identify the functional capabilities
needed by your laboratory employees as well as the minimum qualifi­
cations for individuals who fill the positions. Laboratories conducting 
moderate complexity testing must have employees who qualify and can 







It is possible for the same individual, if qualified, to perform more than 
one of these functions; he or she may even fill all four positions.
The laboratory director is responsible for the overall operation and 
administration of the laboratory. To qualify as director, an individual 
who is a doctor of medicine or osteopathy must either be a pathologist 
or have had at least 1 year of experience directing or supervising 
moderate or high complexity laboratory testing. If you are an MD or 
DO and do not have this experience, you can continue to serve as a 
laboratory director by earning at least 20 continuing medical education 
(CME) hours in laboratory practice by one year after the publication 
date of the regulations. You can also qualify as director if you have 
obtained laboratory training during your medical residency equivalent 
to 20 CME hours. Individuals who have doctoral, master’s, or 
bachelor’s degrees in one of the biological, chemical, physical, or 
clinical laboratory sciences can also qualify as laboratory directors if 
they have the appropriate training and experience. In addition, if you 
were qualified on the date the regulations were published under state 
law to direct a laboratory in the state in which your laboratory is 
located, you remain qualified.
What are the required qualifications and functions o f  
the clin ica l and technical consultant?
The clinical consultant must be either a physician or a board-certified 
doctoral level scientist. He or she serves as the liaison between the 
laboratory and its clients in reporting and interpreting results.
The technical consultant is responsible for the technical and scientific 
oversight of the laboratory. The employee who performs this function 
must have a medical degree or an undergraduate or advanced degree in 
one of the sciences and 1 or 2 years of specific laboratory training or 
experience in the laboratory specialty of the consultation.
In a POL, a physician would most likely serve as the clinical consultant 
and may also serve as the technical consultant, if he or she has at least 1 
year of training or experience in the appropriate area of laboratory 
service. For example, if you are a physician and you or your staff 
perform several hematology, chemistry, and microbiology tests in your 
office, you must have either 1 year of experience in conducting these 
tests in your office or a total of 1 year of training or experience in 
hematology, chemistry, and microbiology to qualify as technical 
consultant. If you or someone else in your office laboratory cannot
meet the requirements, you must hire a qualified person(s) as a consult­
ant to perform the technical functions until you or a staff member 
acquire the necessary experience. The technical consultant must be 
available on an as-needed basis and is responsible for selecting test 
methods and establishing their performance characteristics, implement­
ing a QC program, enrolling in and monitoring proficiency testing, 
resolving technical problems, evaluating the competency and perfor­
mance of testing personnel, and providing training.
Q ■ Can the nurse in my office continue to perform  the 
laboratory testing?
9L. In most cases, yes. The testing personnel for moderate complexity
testing must have, at minimum, a high school diploma and documenta­
tion of satisfactory completion of training appropriate to the testing 
performed in your office or clinic laboratory. This training may have 
been obtained either formally or informally on the job. If you are 
performing high complexity testing in your laboratory, a nurse may not 
qualify unless he or she can meet specific education requirements.
Q. Does my laboratory have to change the w ay w e are  
perform ing laboratory tests?
CH. Perhaps. If you have not been performing adequate QC procedures and 
your laboratory conducts tests not categorized as waived, you will need 
to begin performing routine QC procedures and documenting their 
results. During the first 2 years of CLIA implementation, if you are 
performing moderate complexity tests using systems cleared by the 
FDA for in vitro diagnostic use, your laboratory must, at minimum, 
follow the manufacturer’s instructions, perform and document calibra­
tion procedures at least once every 6 months, run two levels of controls 
daily, perform applicable specialty and subspecialty QC procedures, 
prepare a procedure manual, and perform and document remedial 
action taken when errors are identified.
If your laboratory performs either moderate complexity testing using 
systems cleared for in vitro diagnostic use that you have modified or 
high complexity testing, you must follow all applicable QC rules listed 
in the regulations.
During the first 2 years of implementation, the FDA will begin clearing 
tests as meeting CLIA QC requirements. This means that after mid- 
1994, you will meet most of the CLIA QC requirements by following 
the test manufacturer’s instructions when using systems cleared in this 
manner.
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Q- Do I have to change the w ay I’m using laboratory tests  
in  my practice?
d . No. CLIA does not apply to the use of laboratory test results or to the 
medical decision-making process. It focuses specifically on standards 
for laboratory test performance.
Q,. What is proficiency testin g  and how  does it rela te to 
my office laboratory?
Proficiency testing (PT), mandated by CLIA, is an external evaluation 
of the quality of a laboratory’s performance. When your laboratory 
enrolls in an approved PT program, you will receive specimens to 
evaluate in the same way that you routinely test patient specimens. In 
general, PT programs will provide five samples for each analyte or test 
3 times per year (i.e., 3 testing events per year). After your laboratory 
has tested the samples, you must return the results to the PT program 
for grading, where your laboratory’s results will be compared with the 
consensus answer from referee laboratories for the same specimens. 
With a few exceptions, the passing score is 80%.
PT is being phased in gradually to allow laboratories and PT program 
providers sufficient time to meet the requirements. Newly regulated 
laboratories, including most POLs, must enroll in a PT program during 
1993 to begin participating in 1994. By that time your laboratory must 
participate in programs for each specialty, subspecialty, analyte, or test 
for which it is certified and for which PT is required.
Q. What happens if  my laboratory fa ils PT?
j/f. If your laboratory receives a failing score for an analyte, test,
subspecialty or specialty, you or your laboratory personnel must take 
necessary actions to find, correct, and document any problems in the 
testing performance. If a laboratory fails two consecutive or two out of 
three PT events, the laboratory will be subject to penalties. Newly 
regulated laboratories, however, will not be penalized for PT failures 
until 1995, although they will be expected to correct whatever problems 
resulted in failure. This means your laboratory will have 1 year to learn 
how PT works before penalties for failure will be incurred. If failure is 
so severe as to suggest that patient health and safety is jeopardized, 
however, immediate action will be taken.
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Q. Will my office laboratory be in spected  and, if  so, w hat 
w ill the inspection  involve?
¡X, If your laboratory conducts nonwaived testing, an inspection will occur 
within the first 2 years after you register with the Health Care Financ­
ing Administration (HCFA). During an inspection you or your 
laboratory personnel may be asked to perform procedures, show an 
inspector all of the areas of the laboratory, and provide requested 
documentation. After your laboratory is certified, inspections will be 
conducted every 2 years or, if necessary, as part of a complaint investi­
gation. Inspections may occur without prior notice.
Q ■ How do I sign up?
J/T. First, you must obtain either a certificate of waiver or, if your labora­
tory performs nonwaived testing, a registration certificate. If you have 
not already been contacted by HCFA about CLIA you may obtain 
information and an application from the HCFA office in your region. 
The regional offices are listed on the last 2 pages of this brochure. 
Registration certificates are valid for a maximum of 2 years or until 
such time as an inspection can be conducted to determine program 
compliance, whichever is shorter. Certificates are issued to laborato­
ries complying with the Department program and certificates of 
accreditation to those complying with Department-approved, private, 
nonprofit accreditation programs. In addition, in states with Federally 
approved licensure programs a laboratory may obtain a state license in 
lieu of a certificate or certificate of accreditation. If your laboratory is 
located in a state with an approved program and you obtain a state 
license, you will have only to comply with the state rules, not the 
Federal CLIA regulations. In choosing which type of certification to 
seek, you may consider factors such as cost, convenience, professional 
affiliations, and other considerations beyond the scope of this discus­
sion.
Q. What costs are involved for laboratories to m eet the  
CLIA regulations?
¿/f. The major costs to all laboratories involve fees for certification and 
compliance and enrollment in PT programs. These costs will vary, 
depending on the amount of testing conducted in the laboratory and on 
the types of PT programs in which the laboratory enrolls.
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Laboratories conducting only waived testing must pay a fee of $100 to 
obtain a certificate of waiver. Fees for registration certificates for most 
POLs will range from $100 to $350, depending on testing volume and 
the number of laboratory specialties for which the laboratory seeks 
certification. Inspection fees will also be assessed on the basis of 
volume of testing and types of services. The costs associated with 
participating in PT will vary by the number of tests for which the 
laboratory participates and the PT program. In general, PT costs will 
be lower for laboratories conducting limited testing than for those 
conducting a large variety of tests in several specialties or 
subspecialties. Some laboratories may incur additional costs associated 
with increased QC activities, quality assurance implementation, 
training for personnel, and hiring of consultants.
H ow can I obtain m ore inform ation about the  
regulations?
You can order copies of the Federal Register containing the CLIA 
standards for laboratories and the preliminary list of tests in the 






Specify the date of the issue that you are requesting (February 28,
1992) and your choice of paper or microfiche format Enclose a check 
or money order payable to the Superintendent of Documents. Credit 
card orders can also be placed by calling the order desk at (202) 783- 
3238 or by faxing to (202) 512-2250. In addition, you may view and 
photocopy the Federal Register at most libraries designated as U.S. 
Government Depository Libraries and at many other public and 
academic libraries throughout the country. The order desk operator can 
tell you the location of the nearest U.S. Government Depository 
Library.
R egional Offices o f the H ealth Care F inancing A dm inistration
REGION I
(CT, ME, MA, NH, RI, VT) 
Room 1211 
JFK Federal Building 
Boston, MA 02203 
(617) 565-1322
REGION II
(NJ, NY, PR, VI)
Room 3821 
26 Federal Plaza 
New York, NY 10278 
(212)264-1121
REGION III
(DE, DC, MD, PA, VA, WV) 
3535 Market Street 
P.O. Box 7760 
Philadelphia, PA 19101 
(215) 596-6571
REGION IV
(AL, FL, GA, KY, MS, NC, SC, TN) 
Suite 601 
101 Marietta Tower 
Atlanta, GA 30323 
(404) 841-2361
REGION V
(IL, IN, MI, OH, WI)
105 West Adams Street 
15 th Floor 
Chicago, IL 60603-6201 
(312) 353-9804
REGION VI
(AR, LA, NM, OK, TX)
Room 1935 
1200 Main Tower Building 




(IA, KS, MO, NE)
New Federal Office Building 
601 East 12th Street, Room 242 
Kansas City, MO 64106 
(816) 426-2408
REGION Vm
(CO, MT, ND, SD, UT, WY) 
Federal Building 
1961 Stout Street, Room 1185 
Denver, CO 80294 
(303) 844-4721
REGION IX
(AZ, CA, HI, NV, US Pacific Islands) 
75 Hawthorne Street 
4th Floor 
San Francisco, CA 94105 
(415) 744-3679
REGION X
(AK, ID, OR, WA)
2201 Sixth Avenue 
Mail Stop RX-42 
Seattle, WA 98121 
(206) 553-0511
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